ABCB1 and cancer: Since ABCB1 expression in normal tissues leads to higher toxicity in cancer treatment using an ABCB1 inhibitor [3], researchers have focused on the molecular pathway of MDR cancer cells as a strategy in the development of new molecular targets [4].